Evofem Strengthens Phexxi® Intellectual Property with New Composition of Matter Patent From USPTO
June 30, 2022
Diffusion Pharmaceuticals Reports Positive Trend in Oxygenation from TCOM Trial
June 30, 2021
Related Post
-
-
Todos Medical Announces Positive Biomarker Data from Phase 2 Trial of Tollovir in Hospitalized COVID-19 Patients
June 30, 2022
-
Adial Pharmaceuticals Provides Letter to Shareholders From CEO William Stilley
June 28, 2022
-
Evofem Reaches Agreement with One of the Largest Pharmacy Benefit Managers in the U.S. for Access to Phexxi®
June 28, 2022